Richard A Moravec

Cell Viability Assays

Terry Riss, Richard A Moravec, Andrew L. Niles et al. · Europe PMC (PubMed Central) · 2016 · 470 citations

Immunocytochemical Technique, Immunology, Blood Cell +17

Use of Multiple Assay Endpoints to Investigate the Effects of Incubation Time, Dose of Toxin, and Plating Density in Cell-Based Cytotoxicity Assays

Terry Riss, Richard A Moravec · Assay and Drug Development Technologies · 2004 · 362 citations

A homogeneous assay to measure live and dead cells in the same sample by detecting different protease markers

Andrew L. Niles, Richard A Moravec, P. Eric Hesselberth et al. · Analytical Biochemistry · 2007 · 168 citations

Different Protease Markers, Immunocytochemical Technique, Cell Division +14

Update on<i>in vitro</i>cytotoxicity assays for drug development

Andrew L. Niles, Richard A Moravec, Terry Riss · Expert Opinion on Drug Discovery · 2008 · 150 citations

In Vitro Viability and Cytotoxicity Testing and Same-Well Multi-Parametric Combinations for High Throughput Screening

Andrew L. Niles, Richard A Moravec, Terry Riss · Current Chemical Genomics · 2009 · 146 citations · Full text

Immunology, Toxicology Testing, Vitro Viability +19